Facebook Linkedin Twitter
Inside Precision Medicine Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced Cancer

Cancer testing

Harmonizing NGS standards is expected to provide a strong evidence base for decisions on coverage of clinical genomic testing and treatment for cancer. [iStock / zmeel]
Molecular Dx

Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced Cancer

Alice McCarthy
0
Female scientist is dissecting a breast tumor sample that has been cut on a glass slide, so that she can take out the relevant tumor cells from the slide and extract DNA and subject these to molecular profiling and AI-analysis as carried out by Ataraxis AI.
Informatics

Precision Cancer Diagnostic Firm Ataraxis AI Launches

0
DNA code on large LED screen with black background out of focus
News & Features

Myriad and Flatiron Integrate Genetic Testing with Electronic Medical Record Platform

0
Image of gut and intestines showing colorectal cancer highlighted in red.
Molecular Dx

Geneoscopy’s RNA-Based Colorectal Cancer Test Approved by FDA

0
Illustration of female reproductive system including uterus and ovaries to represent ovarian cancer
News & Features

Ambry Launches INTERACT Collaboration to Spur Hereditary Cancer Testing

0
Cancer cells
News & Features

New Frontiers in Liquid Biopsy

Chris Anderson
0
Tongue cancer medical concept or squamous cell carcinoma as malignant tumor disease. 3d illustration
News & Features

Point of Care Device Validated for Oral Cancer

0
Blood draw for liquid biopsy.
News & Features

Veracyte Adds AI-Driven MRD Testing Capabilities with C2i Genomics Acquisition

Jonathan D. Grinstein, PhD
0
Ovarian Cancer
News & Features

Smear Test Flags Ovarian Cancer

0
PSA test
Oncology

Black Men More Likely than White Men to Have Prostate Cancer at Same PSA Levels

0
123...8Page 1 of 8

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine